JW SHINYAK CORPORATION

067290 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩3,515.00
-2.90%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.43.
  • Comfortable interest cover: operating profit covers interest about 9.1 times.
  • Return on equity is healthy at 38.4%.
  • Return on capital employed is healthy at 17.4%.
  • Net profit margin is strong at 19.3%.
  • Current assets comfortably cover current liabilities (current ratio 1.69).
  • Profit has compounded about 49% a year over five years.

!Watch-points

  • Sales growth has been slow over five years (about -4% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
0.75

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
3 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩1,964억
Current Price₩ 3,515.00
High / Low₩ 4,335.00 / 0.00
Stock P/E11.95
Book Value₩ 765.28
ROCE17.41%
ROE38.44%
Debt to Equity0.43
Current Ratio1.69
EPS₩ 294.19
PAT Margin19.32%
ICR9.07
Compounded Sales Growth
10 Years
5 Years -3.84%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years 48.76%
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year 38.44%
Educational data only. Not a recommendation to buy, sell or hold any security.